Income Taxes (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
| Income Taxes [Abstract] |
|
| Schedule of Income Tax Expense |
Income tax expense for the years ended December 31, 2025, 2024
and 2023 consist of the following (in thousands):
| | |
Year ended December 31, | |
| | |
2025 | | |
2024 | | |
2023 | |
| Current: | |
| | |
| | |
| |
| Federal | |
$ | — | | |
$ | (114 | ) | |
$ | (167 | ) |
| State | |
| 207 | | |
| 177 | | |
| 217 | |
| Total current | |
| 207 | | |
| 63 | | |
| 50 | |
| Deferred: | |
| | | |
| | | |
| | |
| Federal | |
| — | | |
| — | | |
| (42 | ) |
| State | |
| — | | |
| — | | |
| — | |
| Total deferred | |
| — | | |
| — | | |
| (42 | ) |
| Income tax expense | |
$ | 207 | | |
$ | 63 | | |
$ | 8 | |
|
| Schedule of Income Tax Expense Amount Computed at the Federal Statutory Corporate |
The effective income tax rate for the year ended December 31, 2025
differs from the statutory federal income tax rate as follows (in thousands, except percentages):
| |
|
Year ended
December 31, 2025 |
|
| |
|
Amount |
|
|
Percentage |
|
| Tax benefit at Federal statutory rate |
|
$ |
(10,774 |
) |
|
|
21.00 |
% |
| State and local income tax, net of federal (national) income tax effect(f) |
|
|
207 |
|
|
|
-0.40 |
% |
| Tax Credits |
|
|
(211 |
) |
|
|
0.41 |
% |
| Change in valuation allowance |
|
|
13,821 |
|
|
|
-26.94 |
% |
| Nontaxable or nondeductible items |
|
|
|
|
|
|
|
|
| Stock Compensation |
|
|
573 |
|
|
|
-1.12 |
% |
| Change in fair value - warrant liabilities |
|
|
(3,612 |
) |
|
|
7.04 |
% |
| Other |
|
|
101 |
|
|
|
-0.20 |
% |
| Other Adjustments |
|
|
102 |
|
|
|
-0.20 |
% |
| Income tax (benefit) expense |
|
$ |
207 |
|
|
|
-0.40 |
% |
| (f) | State taxes in Oregon and Texas made up the majority (greater
than 50 percent) of the tax effect in this category. |
| | |
2024 | | |
2023 | |
| Tax (provision) benefit at Federal statutory rate | |
$ | (20,587 | ) | |
$ | (25,454 | ) |
| State income tax provision (benefit), net of federal benefit | |
| (5,238 | ) | |
| (6,235 | ) |
| Noncontrolling interest | |
| 44 | | |
| 96 | |
| Tax receivable agreement liability | |
| — | | |
| — | |
| Change in fair value – warrant liabilities | |
| (736 | ) | |
| — | |
| Change in valuation allowance | |
| 26,963 | | |
| 35,592 | |
| Remeasurement due to rate change | |
| (586 | ) | |
| (31 | ) |
| Research and development tax credits | |
| (482 | ) | |
| (1,113 | ) |
| Remeasurement of investment in Purple LLC | |
| — | | |
| (4,028 | ) |
| Nondeductible compensation | |
| 315 | | |
| 281 | |
| Stock-based compensation | |
| 699 | | |
| 605 | |
| Other | |
| (329 | ) | |
| 295 | |
| Income tax expense | |
$ | 63 | | |
$ | 8 | |
|
| Schedule of Deferred Income Taxes |
Deferred income taxes at December 31, 2025 and 2024 consisted
of the following (in thousands):
| | |
2025 | | |
2024 | |
| Basis difference in Purple LLC investment | |
$ | 140,085 | | |
$ | 153,872 | |
| Tax over book basis in capital contributions | |
| 80,123 | | |
| 79,400 | |
| Start-up costs | |
| 319 | | |
| 361 | |
| Stock-based compensation | |
| 377 | | |
| 635 | |
| Interest carryforwards | |
| 12,903 | | |
| 6,503 | |
| Research and development tax credits | |
| 3,838 | | |
| 3,590 | |
| Charitable contribution carryforwards | |
| 160 | | |
| 159 | |
| Net operating losses | |
| 100,982 | | |
| 82,137 | |
| Total net deferred income tax asset | |
| 338,787 | | |
| 326,657 | |
| Less: Valuation allowance | |
| (338,787 | ) | |
| (326,657 | ) |
| Net deferred income tax asset | |
$ | — | | |
$ | — | |
|
| Schedule of Change in Valuation Allowance |
The following table summarizes
the Company’s change in valuation allowance for the year ending December 31, 2025 and 2024 (in thousands):
| | |
2025 | | |
2024 | |
| Valuation allowance — beginning of period | |
$ | 326,657 | | |
$ | 303,780 | |
| Additions charged to income tax benefit | |
| 19,002 | | |
| 27,998 | |
| Allowances taken or written off | |
| — | | |
| — | |
| Deductions charged to other accounts | |
| (6,872 | ) | |
| (5,121 | ) |
| Valuation allowance — end of period | |
$ | 338,787 | | |
$ | 326,657 | |
|
| Schedule of Unrecognized Tax Benefits |
The following table summarizes the Company’s unrecognized tax
benefits for the years ended December 31, 2025, 2024 and 2023 (in thousands):
| | |
Unrecognized Tax Benefits | |
| Unrecognized tax benefits as of December 31, 2023 | |
| 946 | |
| Increase due to current year tax positions | |
| 111 | |
| Increase due to prior year tax positions | |
| 109 | |
| Decrease due to lapse of statute of limitations | |
| (114 | ) |
| Unrecognized tax benefits as of December 31, 2024 | |
$ | 1,052 | |
| Increase due to current year tax positions | |
| 41 | |
| Increase due to prior year tax positions | |
| 21 | |
| Decrease due to lapse of statute of limitations | |
| — | |
| Unrecognized tax benefits as of December 31, 2025 | |
$ | 1,114 | |
|